ArticleCase reports in women's health2026
Cytomegalovirus hepatitis in early pregnancy: A case report.
Article in Case reports in women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus (CMV) is a ubiquitous herpesvirus infecting a large proportion of the population worldwide. Clinical manifestations range from asymptomatic infection to severe disease with multi-organ involvement, depending primarily on host immune status. CMV hepatitis is an uncommon clinical presentation. In pregnancy, infection is usually asymptomatic in immunocompetent women; however, transplacental transmission may occur, leading to congenital infection. Congenital CMV is the most common congenital viral infection. This report describes the case of a 30-year-old pregnant woman with acute CMV infection acquired during the first trimester. The disease manifested as hepatitis, with ALT and AST levels reaching up to 31-fold and 15-fold above the upper limits of normal, respectively. Gradual improvement was observed with supportive treatment, and the outcome was favourable for both mother and child. The infant was delivered at term and has shown normal development; at 8 years of age, the only reported condition is lactose intolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.